Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: An 8-year retrospective single-center study

Table 1 Patient characteristics at admission

Sex (female/male )	26/38
Age at admission (yr)	32.05 ± 2.00
Age at first diagnosis of portal cavernoma ( ≤ 18 yr/> 18 yr)	26/38
History of portal cavernoma (yr)	3.68 ± 0.78
Clinical presentations
Abdominal distension	37
Abdominal pain	26
Variceal bleeding	29
Degree of varices (high risk/low risk/no varices)	6/12/1946
Ascites	20
Degree of ascites (grade III/grade II/grade I/no ascites)	3/1/16/44
Hydrothorax	10
Laboratory tests
RBC (1012/L)	3.95 ± 0.11
Hb (g/L)	106.25 ± 4.00
WBC (109/L)	8.11 ± 1.03
PLT (109/L)	298.73 ± 33.67
PT (s)	14.14 ± 0.24
INR	1.15 ± 0.02
ALT (U/L )	29.97 ± 3.31
AST (U/L)	30.28 ± 2.64
ALP (U/L)	107.21 ± 7.68
GGT (U/L)	41.16 ± 5.96
ALB (g/L)	38.25 ± 0.58
TBIL (μmol/L)	16.05 ± 1.32
Serum Cr (μmol/L)	70.65 ± 2.48
Serum Na (mmol/L)	139.54 ± 0.45
Child-Pugh class (A/B/C)	12/1/1951
Child-Pugh score	5.70 ± 0.13
MELD score	4.25 ± 0.53
Location and degree of obstruction
Main portal vein (patent/partial/complete/fibrotic cord)	5/5/12/42
Right portal vein obstruction	49
Left portal vein obstruction	51
Splenic vein obstruction and splenectomy	39
Superior mesenteric vein obstruction	34

Data are expressed as quantitative data as frequency or mean ± SE. RBC: Red blood cell; Hb: Hemoglobin; WBC: White blood cell; PLT: Platelets; PT: Prothrombin time; INR: International normalized ratio; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; GGT: γ-glutamyl transferase; ALB: Albumin; TBIL: Total bilirubin.